-- 受中国国内市场降温的影响,上汽集团(SHA:600104)公布2026年第一季度业绩与上年同期持平。 根据上汽集团周四向上海证券交易所发布的最新财报,其归属于母公司股东的净利润小幅增长0.9%,从30.2亿元人民币增至30.3亿元人民币。 每股收益小幅增长0.265元人民币,从0.264元人民币增至0.265元人民币,高于Visible Alpha调查中分析师预测的0.13元人民币。 总营业收入同比下滑0.3%,从上年的1409亿元人民币降至1404亿元人民币,低于Visible Alpha预测的1414亿元人民币。 中国乘用车协会的数据显示,3月份中国汽车销量连续第六个月下滑,国内汽车销量也随之出现疲软,这与中国汽车行业的整体低迷趋势相符。 路透社4月初报道称,受中东冲突导致油价上涨的影响,3月份中国国内汽车销量同比下降15.2%,至167万辆。 另一方面,3月份中国汽车出口量增长73.7%,接近70万辆。 上汽集团也未能幸免于这些趋势。3月份,上汽集团销量下降2.6%,至375,870辆;产量下降9.1%,至355,336辆。 为了吸引更多消费者,上汽集团近期加大了合作力度,最近与Vala(HKG:2051)达成车型开发协议,共同开发一款新车型。 上汽集团近期还披露了与德国奥迪合作开发的第三款车型计划,该车型将于2027年面世。他们的第二款SUV车型奥迪E7X已在今年的北京车展上亮相。 据彭博社周五援引知情人士报道,上汽集团还计划在西班牙建立一家电动汽车工厂,进一步拓展其在欧洲的业务。 尽管匈牙利近年来在电动汽车和电池领域的投资颇多,此前也曾被考虑在内,但彭博社援引消息人士的话称,上汽集团最终选择西班牙作为其电动汽车工厂的选址,因为西班牙提供了一系列优惠政策,并且一直致力于将自身打造成为电动汽车投资中心。
Related Articles
Berenberg Adjusts Estimates for Galp Energia After 'Solid' Q1 Results; Hold Rating Maintained
Berenberg updated its earnings forecasts for Galp Energia (GALP.LS) after the Portuguese energy company reported its first-quarter results."Galp reported a solid set of results for Q126 on 27 April from an operational point of view, and beat consensus EBITDA expectations, although this was offset by some cash flow adjustments in the period. Delivery of the important Bacalhau project (Brazil) appears to be ahead of expectations, and, after a strong Q1 in the refining business, Galp is moving towards confirming the terms of its downstream merger with Moeve. In the earnings call, the company indicated that its 2026 guidance is now likely out of date given the macro backdrop, and that it may update its FY26 outlook in the Q2 results. We leave our Hold rating and EUR20 price target unchanged," the research firm said Wednesday.Against this backdrop, the research firm increased its 2026 EBITDA assumption by 3%, while cutting its cash flow from operations and free cash flow estimates by 4% and 3%, respectively, to account for a recent 320 million-euro renewable acquisition and other liquidity adjustments.Meanwhile, analysts maintained their share repurchase projection for 2026 at 250 million euros, while boosting their 2027 forecast to 455 million euros, which is 10% above consensus. Berenberg's EPS estimates for 2026 through 2028 were also revised upwards.
Henlius Biotech Doses First Patient in Lung Cancer Drug Trial in China
Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a phase 1 clinical study of HLX3901 in mainland China, according to a Thursday Hong Kong bourse filing.The drug is being tested for the treatment of patients with advanced small-cell lung cancer or neuroendocrine carcinoma.
BP Confirms Preliminary Offshore Exploration Agreement With Venezuela
BP (BP.L) entered into a memorandum of understanding with the Bolivarian Republic of Venezuela to establish "potential areas for co‑operation in material offshore gas and future exploration," according to a statement sent toon Thursday.Venezuela's Acting President Delcy Rodríguez announced in a Wednesday signing event its offshore natural gas exploration deal with the British oil major, which covers the Deltana Platform, an oil and natural gas reservoir in the nation's eastern waters, according to a same-day report from Bloomberg News.BP Executive Vice President William Lin also said the company plans to launch a permanent regional office in Caracas, Venezuela.